This editorial invites readers to weigh in on whether The Oncologist should expend the considerable effort and expense to produce a peer-reviewed, searchable venue for publishing the results of all well-executed cancer trials that fail to meet positive endpoints.
No takes yet. Share an insight, caveat, or question.
Curt et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: